Hepatic resection for breast cancer related liver metastases: A single institution experience.
Ian S ReynoldsPaul M CromwellJanice M WalsheJohn CrownDonal MaguireJustin GeogheganNiall SwanEmir HotiPublished in: Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society (2022)
This study has demonstrated that liver resection for breast cancer-related liver metastases is feasible, safe and associated with prolonged disease free and overall survival in selected patients. It is likely that this option will be offered to more patients going forward, however, the difficulty lies in selecting out those who will benefit from liver resection particularly given the increasing number of systemic treatments and local ablative methods available that offer good long-term results.